Sign in
4

Changes in Ownership

Vanda Pharmaceuticals Inc. Filed Acc 0001209191-13-055363

Options or other derivatives

  • President and CEO acquired 200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Polymeropoulos Mihael Hristos · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-12-02 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +150,000 $11.59 2023-12-01 150,000 150,000 D
2013-12-02 Grant or award : show line 2 in the form Restricted Stock Unit +50,000 50,000 50,000 D
Loading xslF345X03/doc4.xml…